Trial Profile

A phase II trial of LMI-1195 for use in cardiac PET to assess myocardial presynaptic sympathetic nerve function

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 15 Mar 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Flubrobenguane-(18F) (Primary)
Indications Heart failure; Ischaemic heart disorders
Focus Diagnostic use

Most Recent Events

15 Mar 2018 New trial record
12 Mar 2018 Data from this trial will be presented at the American College of Cardiology's 67th Annual Scientific Session (ACC.18), according to a Lantheus Medical Imaging media release.
12 Mar 2018 Results presented in a Lantheus Medical Imaging media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com